Pain relief without opioids? lidocaine dosing trial for bariatric surgery
NCT ID NCT03095404
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to find the best dose of intravenous lidocaine for controlling pain after bariatric bowel surgery. Lidocaine is a local anesthetic that may reduce the need for opioids, which can cause nausea and other side effects. The trial planned to compare two doses in adults undergoing major bowel surgery, but it was withdrawn before any participants were enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
lidocaine
What this could lead to
If successful, this could point toward a standard lidocaine dosing schedule to improve pain relief and reduce opioid use after bariatric surgery.
What could go wrong
This trial was withdrawn before enrolling any participants, so no data exists. The findings may not apply to other surgeries or patient groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARIATRIC SURGERY CANDIDATE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.